Feb 21, 2007
Notice
Kringle Pharma and Tripep AB, a Swedish biotechnology research company, reached to a basic agreement to co-develop recombinant human HGF (Hepatocyte Growth Factor) protein for wound healing therapy.
Kringle Pharma and Tripep AB, a Swedish biotechnology research company, reached to a basic agreement to co-develop recombinant human HGF (Hepatocyte Growth Factor) protein for wound healing therapy.